Subtle anomaly detection: Application to brain MRI analysis of de novo Parkinsonian patients.

Machine learning Neurodegenerative disease Parkinson's disease Unsupervised learning Variational autoencoder

Journal

Artificial intelligence in medicine
ISSN: 1873-2860
Titre abrégé: Artif Intell Med
Pays: Netherlands
ID NLM: 8915031

Informations de publication

Date de publication:
03 2022
Historique:
received: 08 02 2021
revised: 26 11 2021
accepted: 29 01 2022
entrez: 4 3 2022
pubmed: 5 3 2022
medline: 1 4 2022
Statut: ppublish

Résumé

With the advent of recent deep learning techniques, computerized methods for automatic lesion segmentation have reached performances comparable to those of medical practitioners. However, little attention has been paid to the detection of subtle physiological changes caused by evolutive pathologies, such as neurodegenerative diseases. In this work, we leverage deep learning models to detect anomalies in brain diffusion tensor imaging (DTI) parameter maps of recently diagnosed and untreated (de novo) patients with Parkinson's disease (PD). For this purpose, we trained auto-encoders on parameter maps of healthy controls (n = 56) and tested them on those of de novo PD patients (n = 129). We considered large reconstruction errors between the original and reconstructed images to be anomalies that, when quantified, allow discerning between de novo PD patients and healthy controls. The most discriminating brain macro-region was found to be the white matter with a ROC-AUC 68.3 (IQR 5.4) and the best subcortical structure, the GPi (ROC-AUC 62.6 IQR 5.4). Our results indicate that our deep learning-based model can detect potentially pathological regions in de novo PD patients, without requiring any expert delineation. This may enable extracting neuroimaging biomarkers of PD in the future, but further testing on larger cohorts is needed. Such models can be seamlessly extended with additional parameter maps and applied to study the physio-pathology of other neurological diseases.

Identifiants

pubmed: 35241258
pii: S0933-3657(22)00016-1
doi: 10.1016/j.artmed.2022.102251
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102251

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.

Auteurs

Verónica Muñoz-Ramírez (V)

Univ. Grenoble Alpes, Inria, CNRS, Grenoble INP, LJK, 38000 Grenoble, France; Univ. Grenoble Alpes, Inserm U1216, CHU Grenoble Alpes, Grenoble Institut des Neurosciences, 38000 Grenoble, France.

Virgilio Kmetzsch (V)

Univ. Grenoble Alpes, Inria, CNRS, Grenoble INP, LJK, 38000 Grenoble, France; Univ. Grenoble Alpes, Inserm U1216, CHU Grenoble Alpes, Grenoble Institut des Neurosciences, 38000 Grenoble, France.

Florence Forbes (F)

Univ. Grenoble Alpes, Inria, CNRS, Grenoble INP, LJK, 38000 Grenoble, France.

Sara Meoni (S)

Univ. Grenoble Alpes, Inserm U1216, CHU Grenoble Alpes, Grenoble Institut des Neurosciences, 38000 Grenoble, France; Division of Neurology, CHU Grenoble Alpes, 38000 Grenoble, France.

Elena Moro (E)

Univ. Grenoble Alpes, Inserm U1216, CHU Grenoble Alpes, Grenoble Institut des Neurosciences, 38000 Grenoble, France; Division of Neurology, CHU Grenoble Alpes, 38000 Grenoble, France.

Michel Dojat (M)

Univ. Grenoble Alpes, Inserm U1216, CHU Grenoble Alpes, Grenoble Institut des Neurosciences, 38000 Grenoble, France. Electronic address: michel.dojat@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH